NeuroScios GmbH Information

With 30 years of experience in CNS drug development we may offer you the fastest track from molecule to clinic. As a contract research organization we -Support the development of new treatments for CNS diseases -Alzheimer’s disease -Parkinson’s disease -Orphan neurodegenerative disorders -Cerebrovascular diseases -Psychiatric diseases -Accelerate the drug/ treatment development by our profound knowledge of the requirements -Pharmacology -ADME -Toxicology -Regulatory issues (IND/ CTA) - Clinical trials -Optimize the chance of success, by knowing -the most suitable preclinical models -the most experienced and reliable service providers -the competitive environment - Support our clients in the best way by -Designing most efficient individualized development plan -Providing an outstanding network of KOLs in different fields of CNS diseases - Fastest reaction time -Competitive pricing - International experience for more than 30 years